Dr. Vitenas Provides Insight Into Emerging ‘Yoga’ or ‘Ballerina’ Breast Augmentation Trend

1 year ago

Dr. Paul Vitenas Unveils 'Yoga Boobs' Trend for Natural, Athletic Breast Augmentation Using Cutting-Edge TechniquesHOUSTON, TX / ACCESSWIRE / September…

HandicapMD Expands Leading Telemedicine Services for Disabled Parking Permits in Florida

1 year ago

HandicapMD's virtual telemedicine platform connects patients with licensed doctors to obtain disabled parking placards quickly, safely, and affordably. MIAMI, Sept.…

NewSound’s Commitment to Medical Device Excellence: MDD, MDR, and Beyond

1 year ago

XIAMEN, China, Sept. 20, 2024 /PRNewswire/ -- Founded in 2004, the whole family of NewSound has been devoting to offering…

ISI Technology Makes Inc. 5000 List for the Second Consecutive Year

1 year ago

BUFFALO, N.Y., Sept. 20, 2024 /PRNewswire/ -- ISI Technology, a leading provider of software solutions for Non-Emergency Medical Transportation (NEMT)…

Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care

1 year ago

PORTAGE, Mich., USA, Sept. 20, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it…

XpertDox Partners with Blue Fish Pediatrics to Enhance Medical Coding Efficiency with AI-Powered Healthcare Coding Software

1 year ago

XpertDox and Blue Fish Pediatrics Join Forces to Streamline Medical Coding, Enhance Clinical Documentation, and Boost Reimbursement Potential PHOENIX, Sept.…

This Week in Health News: 11 Stories You Need to See

1 year ago

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the latest FDA approvals, health…

BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board

1 year ago

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or…

NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury

1 year ago

Vancouver, British Columbia--(Newsfile Corp. - September 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company…

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

1 year ago

SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare…